Showing results (261-270 of 458) with videos related to
Sort By:
Pageof 46
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2018
Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531Clare J Twist, Arlene Naranjo, Mary Lou Schmidt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trialSteven G DuBois, Louis Chesler, Susan Groshen, et al.Pediatric Blood & Cancer|September 1, 2010
Initial testing (stage 1) of AZD6244 (ARRY-142886) by the Pediatric Preclinical Testing ProgramE Anders Kolb, Richard Gorlick, Peter J Houghton, et al.Pediatric Blood & Cancer|September 11, 2010
Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastomaAlekist Quach, Lingyun Ji, Vikash Mishra, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium studyLars M Wagner, Judith G Villablanca, Clinton F Stewart, et al.Biorxiv : the Preprint Server for Biology|July 15, 2024
Lineage-dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and independent immunotherapeutic targetsNathan M Kendsersky, Michal Odrobina, Nathaniel W Mabe, et al.Nature Communications|April 22, 2020
High throughput pMHC-I tetramer library production using chaperone-mediated peptide exchangeSarah A Overall, Jugmohit S Toor, Stephanie Hao, et al.Pediatric Blood & Cancer|February 9, 2012
Initial testing (stage 1) of the cyclin dependent kinase inhibitor SCH 727965 (dinaciclib) by the pediatric preclinical testing programRichard Gorlick, E Anders Kolb, Peter J Houghton, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
Synergistic activity of PARP inhibition by talazoparib (BMN 673) with temozolomide in pediatric cancer models in the pediatric preclinical testing programMalcolm A Smith, C Patrick Reynolds, Min H Kang, et al.Cancer Causes & Control : CCC|August 20, 2016
A family-based study of gene variants and maternal folate and choline in neuroblastoma: a report from the Children's Oncology GroupAngela L Mazul, Anna Maria Siega-Riz, Clarice R Weinberg, et al.Pageof 46